Daxor
5 hedge funds and large institutions have $926K invested in Daxor in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
23% more capital invested
Capital invested by funds: $755K → $926K (+$171K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 1.76% → 1.74% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$7.23K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$904 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$15.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
DXR Hedge Fund Activity: Q2 2022 in Review
5 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2022, worth a combined $926K — up 23% from $755K a quarter earlier.
Fund positioning in DXR was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $7.23K. The largest seller was Renaissance Technologies, cutting an estimated $15.7K.
- 5 institutional investors held Daxor (DXR) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $926K of Daxor stock for Q2 2022, up 23% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q2 2022 was Wells Fargo, an estimated $7.23K added.
- The largest Daxor seller in Q2 2022 was Renaissance Technologies, an estimated $15.7K sold.
Based on aggregated 13F filings for Q2 2022.